TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15990751

Group type: EXPERIMENTAL
Intervention: Patients with AVB
Number of subjects: 5251

Group type: EXPERIMENTAL
Intervention: Patients with AVB and inferior MI
Number of subjects: 5251

Group type: EXPERIMENTAL
Intervention: Patients with AVB and anterior MI
Number of subjects: 5251

Group type: COMPARATOR
Intervention: Patients without AVB
Number of subjects: 5251
Study: 12519083

Group type: EXPERIMENTAL
Intervention: 0.9% saline (NaCl)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hartmann's solution
Number of subjects: 9
Study: 10486683

Group type: EXPERIMENTAL
Intervention: Self-measurement (SM) of blood pressure using an Omron device for 5 consecutive days (3 measures morning and night)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Office measurements (OM) of blood pressure using a mercury sphygmomanometer (4 measures)
Number of subjects: 32
Study: 8759665

Group type: EXPERIMENTAL
Intervention: Lacteol Fort
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 1810356

Group type: EXPERIMENTAL
Intervention: Controlled release metoclopramide 15 mg (Gastrobid Continus tablets) given twice daily
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Domperidone 10 mg given three times daily
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Domperidone 20 mg given three times daily
Number of subjects: 95

Group type: COMPARATOR
Intervention: Controlled release metoclopramide and domperidone (both doses)
Number of subjects: 95
Study: 6636262

Group type: EXPERIMENTAL
Intervention: Heparinized plasma at 4.0 ng/ml
Number of subjects: 0

Group type: COMPARATOR
Intervention: Serum at 4.0 ng/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard preparation procedures
Number of subjects: 0
Study: 31707814

Group type: EXPERIMENTAL
Intervention: Cinnarizine
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Sodium Valproate
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 31238021

Group type: EXPERIMENTAL
Intervention: Verbal information
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Written information
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Previous surgical experience
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 66
Study: 28510741

Group type: EXPERIMENTAL
Intervention: Early FFP administration (FFP in the CPB priming solution)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Late FFP administration (FFP given immediately after CPB)
Number of subjects: 73
Study: 26036209

Group type: EXPERIMENTAL
Intervention: Huber group (feedback-based balance and core resistance training)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Pilates group (conventional Pilates training)
Number of subjects: 34
Study: 23444177

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide/camphorated paramonochlorophenol (Callen PMCC)
Number of subjects: 21

Group type: COMPARATOR
Intervention: One-visit endodontic treatment
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Callen PMCC
Number of subjects: 21
Study: 21185738

Group type: EXPERIMENTAL
Intervention: Combination of mixed tocopherols 666 IU/day and alpha lipoic acid (ALA) 600 mg/day for 8 weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Matching placebos for 8 weeks
Number of subjects: 62
Study: 18803070

Group type: EXPERIMENTAL
Intervention: Ziprasidone 80‐160 mg/day (n=147)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Olanzapine 10‐20 mg/day (n=24)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Risperidone 4‐8 mg/day (n=22)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Quetiapine 300‐750 mg/day (n=97)
Number of subjects: 293
Study: 17196274

Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation (Heart Manual) for 6 weeks
Number of subjects: 230

Group type: COMPARATOR
Intervention: Hospital-based rehabilitation for 8-10 weeks
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation (Heart Manual)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Hospital-based rehabilitation
Number of subjects: 230
Study: 15554404

Group type: EXPERIMENTAL
Intervention: Circumoral muscle exercises
Number of subjects: 0
Study: 12478024

Group type: EXPERIMENTAL
Intervention: Pneumovax vaccination at 14 days post-splenectomy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pneumovax vaccination at 28 days post-splenectomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal healthy adults (control group)
Number of subjects: 40
Study: 9825977

Group type: EXPERIMENTAL
Intervention: Erythromycin 40 mg/kg/d, intravenously or orally
Number of subjects: 155

Group type: COMPARATOR
Intervention: Not treated (Control)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 155
Study: 7651074

Group type: EXPERIMENTAL
Intervention: Rapeseed oil diet (MUFA)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Sunflower oil diet (PUFA)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Both diets (MUFA and PUFA)
Number of subjects: 59
Study: 2668325

Group type: EXPERIMENTAL
Intervention: sc injections of SMS 201‐995 every 2 hours (q2h)
Number of subjects: 10

Group type: COMPARATOR
Intervention: sc injections of SMS 201‐995 every 8 hours (q8h)
Number of subjects: 10
Study: 1245160

Group type: EXPERIMENTAL
Intervention: Clofibate preparation 1
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Clofibate preparation 2
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Beta-pyridylcarbinol
Number of subjects: 64
Study: 6783523

Group type: EXPERIMENTAL
Intervention: Chemically defined diet (CDD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Water ‐ electrolyte substitution via peripheral veins
Number of subjects: 20
Study: 31525257

Group type: EXPERIMENTAL
Intervention: Xylocaine spray (8 puffs of 10% Lidocaine, 80 mg)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Placebo (8 puffs of sterile normal saline)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Control (no spray)
Number of subjects: 570
Study: 29527345

Group type: EXPERIMENTAL
Intervention: Lay health workers (LHW) supporting nurses in chronic disease care for 18 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control clinics with usual care
Number of subjects: 0
Study: 26799692

Group type: EXPERIMENTAL
Intervention: Simeprevir 150 mg once daily + Sofosbuvir 400 mg once daily for 12 weeks
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Simeprevir 150 mg once daily + Sofosbuvir 400 mg once daily for 8 weeks
Number of subjects: 310
Study: 24117232

Group type: EXPERIMENTAL
Intervention: Adjunctive moderate dose lithium therapy
Number of subjects: 283

Group type: COMPARATOR
Intervention: Optimized treatment
Number of subjects: 283
Study: 22530944

Group type: EXPERIMENTAL
Intervention: eGFR 30.0-59.9 mL/min/1.73 m²
Number of subjects: 5555

Group type: COMPARATOR
Intervention: eGFR ≥ 90.0 mL/min/1.73 m²
Number of subjects: 5555
Study: 20224449

Group type: EXPERIMENTAL
Intervention: Repeated Shuttle Sprint (RS) training
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Explosive Strength (ExpS) training
Number of subjects: 15

Group type: COMPARATOR
Intervention: Both RS and ExpS
Number of subjects: 15
Study: 16926184

Group type: EXPERIMENTAL
Intervention: Combination therapy with sulfasalazine and methotrexate (MTX)
Number of subjects: 687

Group type: COMPARATOR
Intervention: SASP alone
Number of subjects: 687

Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 687
Study: 12760727

Group type: EXPERIMENTAL
Intervention: Intrasphincteric injections of botulinum toxin (group 1: 10 patients)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Injections of 1% polidocanol (group 2: 6 patients)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combined therapy with botulinum toxin and polidocanol (group 3: 6 patients)
Number of subjects: 22
Study: 10995590

Group type: EXPERIMENTAL
Intervention: Upper arm occlusion
Number of subjects: 28

Group type: COMPARATOR
Intervention: Forearm occlusion
Number of subjects: 28
Study: 9357940

Group type: EXPERIMENTAL
Intervention: HIV-infected children with advanced disease
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: HIV-infected patients responding to antiretroviral therapy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 35
Study: 8453557

Group type: EXPERIMENTAL
Intervention: Regional RT plus six cycles of CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Regional RT alone
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Regional RT plus six cycles of CHOP chemotherapy
Number of subjects: 44
Study: 3769386

Group type: EXPERIMENTAL
Intervention: Sotalol 160 mg/day
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Sotalol 240 mg/day
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Sotalol 320 mg/day
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Sotalol (all doses)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 27920153

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26543645

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine, 1 µg/kg (group D)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Midazolam, 0.02 mg/kg (group M)
Number of subjects: 54
Study: 23725006

Group type: EXPERIMENTAL
Intervention: High-Volume Training (HVT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 20
Study: 22080997

Group type: EXPERIMENTAL
Intervention: Real rTMS (20 Hz, 10 second trains, intensity 80% of motor threshold) for 10 minutes daily for five consecutive days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 27
Study: 19898644

Group type: EXPERIMENTAL
Intervention: valsartan +/- HCTZ
Number of subjects: 1285

Group type: COMPARATOR
Intervention: amlodipine +/- HCTZ
Number of subjects: 1285

Group type: COMPARATOR
Intervention: amlodipine
Number of subjects: 1285
Study: 17523002

Group type: EXPERIMENTAL
Intervention: Test product 1 (estradiol and levonorgestrel)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Test product 2 (estradiol and levonorgestrel)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Test product 3 (estradiol and levonorgestrel)
Number of subjects: 2
Study: 15471384

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy
Number of subjects: 83
Study: 11456360

Group type: EXPERIMENTAL
Intervention: Valaciclovir 1000 mg three times daily for 7 days
Number of subjects: 57

Group type: COMPARATOR
Intervention: Acyclovir 800 mg five times daily for 7 days
Number of subjects: 57
Study: 9623637

Group type: EXPERIMENTAL
Intervention: L-T4 replacement treatment in hypothyroid patients
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Restoration of euthyroidism in hyperthyroid patients
Number of subjects: 35
Study: 8186168

Group type: EXPERIMENTAL
Intervention: Question prompt sheet
Number of subjects: 142

Group type: COMPARATOR
Intervention: General information sheet
Number of subjects: 142
Study: 3308052

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 29064128

Group type: EXPERIMENTAL
Intervention: More frequent haemodialysis (6×/week)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Conventional haemodialysis (3×/week)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Nocturnal haemodialysis
Number of subjects: 195
Study: 28422591

Group type: EXPERIMENTAL
Intervention: Papacarie
Number of subjects: 50

Group type: COMPARATOR
Intervention: Atraumatic Restorative Treatment (ART)
Number of subjects: 50
Study: 25264024

Group type: EXPERIMENTAL
Intervention: EMLA cream (4 mg/kg median)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 25
Study: 23553259

Group type: EXPERIMENTAL
Intervention: 1 mL of 4% lidocaine (anesthetized condition)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonanesthetized condition (control)
Number of subjects: 20
Study: 21615734

Group type: EXPERIMENTAL
Intervention: PSSA intervention
Number of subjects: 203

Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 203
Study: 19755925

Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 (P500)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Pemetrexed 1000 mg/m2 (P1000)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group (squamous histology)
Number of subjects: 216
Study: 17092968

Group type: EXPERIMENTAL
Intervention: TPA023 0.5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TPA023 1.5 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lorazepam 2 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15117045

Group type: EXPERIMENTAL
Intervention: 200 mg celecoxib
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 11261347

Group type: EXPERIMENTAL
Intervention: Soft hydrogel contact lenses worn daily for 12 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-diabetic control subjects
Number of subjects: 80
Study: 9853164

Group type: EXPERIMENTAL
Intervention: Enclosed thrombolysis (ET) and percutaneous transluminal angioplasty (PTA)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA) alone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both groups (ET/PTA and PTA)
Number of subjects: 25
Study: 7989433

Group type: EXPERIMENTAL
Intervention: Nested polymerase chain reaction (PCR)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Single round polymerase chain reaction followed by Southern blot hybridization
Number of subjects: 23

Group type: COMPARATOR
Intervention: Virus isolation
Number of subjects: 23
Study: 2543280

Group type: EXPERIMENTAL
Intervention: Intranasal alpha 2b interferon (IFN) 5 x 10(6) IU on day 1 and 2.5 x 10(6) IU on each subsequent day for 5 days
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 31885339

Group type: EXPERIMENTAL
Intervention: Transurethral holmium laser resection (THOLR)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Transurethral electrocision (TUR)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Transurethral holmium laser resection (THOLR) and Transurethral electrocision (TUR) with intravesical epirubicin
Number of subjects: 218
Study: 29742712

Group type: EXPERIMENTAL
Intervention: WORD DPP (faith-based Diabetes Prevention Program)
Number of subjects: 384

Group type: COMPARATOR
Intervention: PILI DPP (Pacific culturally adapted Diabetes Prevention Program)
Number of subjects: 384
Study: 29115949

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 20

Group type: COMPARATOR
Intervention: PSV
Number of subjects: 20
Study: 25727913

Group type: EXPERIMENTAL
Intervention: 1-handed surgical ties (28 students)
Number of subjects: 58

Group type: COMPARATOR
Intervention: 2-handed surgical ties (30 students)
Number of subjects: 58
Study: 23485660

Group type: EXPERIMENTAL
Intervention: Multimodal manual treatment approach (joint mobilization, neural mobilization, and exercise)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo intervention (sham)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Multimodal manual treatment approach
Number of subjects: 60
Study: 22085439

Group type: EXPERIMENTAL
Intervention: Formoterol 4.5 mug bid
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Formoterol 9 mug bid
Number of subjects: 613

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 613
Study: 19662914

Group type: EXPERIMENTAL
Intervention: Aspheric IOLs (Acrysof SN60WF or Tecnis Z9000)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Spherical IOLs (Acrysof SN60AT or Sensar AR40e)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Aspheric IOLs
Number of subjects: 100
Study: 17205144

Group type: EXPERIMENTAL
Intervention: Valsartan (Diovan) 80 mg/day for 7 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 15132875

Group type: EXPERIMENTAL
Intervention: Mosapride 5 mg three times daily for 4 weeks
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Mosapride
Number of subjects: 231

Group type: COMPARATOR
Intervention: Domperidone 10 mg three times daily for 4 weeks
Number of subjects: 231
Study: 11402745

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for two weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily for ten days
Number of subjects: 60
Study: 9143861

Group type: EXPERIMENTAL
Intervention: Carvedilol (25 mg to 50 mg daily after 6 weeks)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 56
Study: 1826192

Group type: EXPERIMENTAL
Intervention: ANF infusion at 1 pmol/kg/min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: ANF infusion at 3 pmol/kg/min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: ANF infusion at 10 pmol/kg/min
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 8
Study: 7057318

Group type: EXPERIMENTAL
Intervention: Lactose elimination diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lactose ingestion (2 gm/kg of body weight; maximum 50 gm)
Number of subjects: 40
Study: 30288602

Group type: EXPERIMENTAL
Intervention: Home-based physical activity programme of 150 min moderate walking per week
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 44
Study: 29064929

Group type: EXPERIMENTAL
Intervention: Concentrated preterm formula at 30 kcal/oz (CPF30)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional powdered human milk fortifier (PHMF)
Number of subjects: 0
Study: 26084590

Group type: EXPERIMENTAL
Intervention: Etanercept continuous regimen (50 mg/week)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Etanercept intermittent regimen
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Etanercept (overall)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Etanercept continuous regimen
Number of subjects: 54
Study: 23289453

Group type: EXPERIMENTAL
Intervention: Central venous catheter (CVC) samples of vancomycin or tobramycin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Peripheral vein samples of vancomycin or tobramycin
Number of subjects: 50
Study: 20667993

Group type: EXPERIMENTAL
Intervention: Belatacept
Number of subjects: 0

Group type: COMPARATOR
Intervention: CNI
Number of subjects: 0
Study: 19583712

Group type: COMPARATOR
Intervention: Colposcopic examination only
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Cervical punch biopsies
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Large loop excision of the transformation zone (LLETZ)
Number of subjects: 929
Study: 17080277

Group type: EXPERIMENTAL
Intervention: Perianal local anesthesia (40 ml of ropivacaine, 4.75 mg/ml, plus 15 ml of ropivacaine, 2 mg/ml)
Number of subjects: 33

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Perianal local anesthesia
Number of subjects: 33
Study: 14971717

Group type: EXPERIMENTAL
Intervention: Flavonoid extract (Colladeen, 320 mg oligomeric procyanidins)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11352620

Group type: EXPERIMENTAL
Intervention: Task-oriented arm training
Number of subjects: 10

Group type: COMPARATOR
Intervention: Passive movements (Control)
Number of subjects: 10
Study: 10186469

Group type: EXPERIMENTAL
Intervention: Ribosomal vaccine (Ribomunyl)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study: 8313547

Group type: EXPERIMENTAL
Intervention: Ridogrel
Number of subjects: 907

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 907
Study: 2968060

Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Loratadine 20 mg
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Loratadine 40 mg
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Loratadine 80 mg
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 29671069

Group type: EXPERIMENTAL
Intervention: MYL-1401H
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference pegfilgrastim (Neulasta® sourced from the EU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference pegfilgrastim (sourced from the USA)
Number of subjects: 0
Study: 27680990

Group type: EXPERIMENTAL
Intervention: Açai-based smoothie (AS)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Macronutrient-matched control smoothie (PS)
Number of subjects: 23
Study: 26111954

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention delivered over two training sessions and a follow-up telephone call
Number of subjects: 107

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 107
Study: 23982208

Group type: EXPERIMENTAL
Intervention: BIS monitoring during balanced propofol sedation
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (standard monitoring)
Number of subjects: 115
Study: 21422465

Group type: EXPERIMENTAL
Intervention: Dialogic argumentation intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group (extensive essay writing practice and whole-class discussion)
Number of subjects: 0
Study: 18310201

Group type: EXPERIMENTAL
Intervention: Sunflower seed oil
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Aquaphor ointment
Number of subjects: 497

Group type: COMPARATOR
Intervention: Control group (no emollient therapy)
Number of subjects: 497
Study: 16698259

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 921

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study: 12823564

Group type: EXPERIMENTAL
Intervention: New antiepileptic drugs (AEDs) in monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 10797177

Group type: EXPERIMENTAL
Intervention: Thrombolysis treatment
Number of subjects: 4342
Study: 8884400

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan (6 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 8396000

Group type: EXPERIMENTAL
Intervention: Delayed thoracic radiotherapy (mean 46.5 Gy-equivalent)
Number of subjects: 53

Group type: COMPARATOR
Intervention: No treatment until relapse
Number of subjects: 53